Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Millimed Holdings acquires Cube Medical
Mandate

Millimed Holdings acquires Cube Medical

May 12, 2005

Millimed Holdings Inc., a newly established US holding company backed by ten Danish and international venture investment funds fronted by Advent International, has agreed to acquire Cube Medical A/S, a Denmark based research, development and production company within the area of vascular medical devices, and Millimed Vascular Intervention AB, a Sweden based sales and marketing company for vascular medical devices. The initial consideration of is USD 12m and an investment of USD 10m contingent upon the achievement of certain milestones.

Vinge acted for Millimed Holdings Inc.
Arne Källén (responsible partner)
Anna Jonsson (associate)

Related

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its rights issue

 Vinge has advised Vicore Pharma Holding AB (publ) in connection with an oversubscribed rights issue of shares whereby Vicore receives issue proceeds of approximately SEK 782 million before deduction of transaction costs.
October 22, 2024

Vinge has advised Vicore Pharma Holding AB (publ) in connection with its directed share issue

 Vinge has advised Vicore Pharma Holding AB (publ) in connection with a directed share issue, whereby Vicore receives issue proceeds of approximately SEK 100 million before deduction of transaction costs.
October 22, 2024

Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS

 Vinge has advised the Swedish state in connection with the reconstruction proceedings of SAS. The proceedings, which included considerations regarding state aid approved by the European Commission, have among other things involved restructuring, debt write-downs as well as an investment by a consortium consisting of Castlelake, Air France-KLM, Lind Invest and the Danish state. In total, the investment amounted to approximately USD 1.2 billion in SAS, divided into USD 475 million in unlisted equity and USD 725 million in convertible debt.
October 21, 2024